OTC lipid ibuprofen first-line treatment for joint pain

Could lipid ibuprofen be a first-line OTC option for flaring joint pain? Joint pain is a common problem with many possible causes. Osteoarthritis (OA) is the most common joint disease in the UK, causing joint pain and stiffness. The knee joint is probably the most frequently affected. As well as joint damage, muscle weakness is a key […]

Read More… from OTC lipid ibuprofen first-line treatment for joint pain

Can diabetes drug really protect the heart?

More work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new research in the journal Diabetes Therapy finds. Examining data from over 60,000 patients with type 2 diabetes, researchers from the University of Surrey discovered that the highly-publicised cardiovascular benefits of the popular diabetes drug empagliflozin […]

Read More… from Can diabetes drug really protect the heart?

Lifestyle changes can reverse Type 2 diabetes

Type 2 diabetes is a public health emergency and the number of people with this disorder has almost doubled since 1996 to nearly four million today. Most people diagnosed with type 2 diabetes, which occurs when the body is no longer able to keep blood sugar levels under control, are put on a lifelong drug […]

Read More… from Lifestyle changes can reverse Type 2 diabetes

Merry Christmas without asthma

Christmas trees, candle fumes and smoking Christmas puddings may be festive but they can all make asthma symptoms worse this holiday season. A sudden change in weather, especially gusts of freezing air, thunderstorms, colds and flu can all trigger asthma attacks. Asthma sufferers have more sensitive airways and the condition can lead to unpleasant symptoms […]

Read More… from Merry Christmas without asthma

A new boost for leukaemia treatment

Leukaemia treatment can be made more effective by using a drug for iron overload, according to new research. Scientists led by a team at Imperial College London have found that chemotherapy for one type of leukaemia could be improved by giving patients a drug currently used to treat an unrelated condition. Acute myeloid leukaemia (AML) […]

Read More… from A new boost for leukaemia treatment

Restricting free OTC prescriptions

NHS England is proposing to draw a new line between when the NHS will help someone, and when citizens are required to fall back on their own private resources when it comes to prescriptions for over-the-counter medicines. This may or may not be a good idea, but it certainly shouldn’t be motivated by a funding […]

Read More… from Restricting free OTC prescriptions

Million Miracles campaign to prevent blindness

Recent figures published by the Lancet show 36 million people are blind, yet 75% of blindness is preventable or treatable. Cataract, which takes just 10 minutes to treat and costs as little as £30, is the leading cause of preventable blindness. Every cataract operation, regardless of who receives it, is like a little miracle – […]

Read More… from Million Miracles campaign to prevent blindness

The price of sight loss

Sight loss costs London’s economy £6.4 billion, around £750 per Londoner, per year, according to a new report Eye Health- preventing sight loss in London, and by 2030, an extra 194,000 Londoners are predicted to have a sight-threatening eye condition and an extra 74,000 with sight loss. Already one in twelve adults in London has […]

Read More… from The price of sight loss

Cannabidiol could treat psychosis

cannabis for severe epilepsy

A constituent of cannabis known as cannabidiol could hold promise as a new class of treatment for psychosis, according to King’s College London research showing significant benefits in a clinical trial. The main psychoactive compound in cannabis is delta-9-tetrahydrocannabinol (THC), which is responsible for many of the drug’s harmful effects, such as paranoia and anxiety. […]

Read More… from Cannabidiol could treat psychosis

No cash, no care

No cash, no care is the reality for many patients in many countries around the world and it is harming the most vulnerable people including refugees, displaced people, pregnant women and children, says Medecins Sans Frontieres At a Malawian health care centre, a mother receives only half of the pills she needs to treat her […]

Read More… from No cash, no care